Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cassia alata extract
- Development stage
- Preclinical
- Administration
- Topical, Oral
01
Overview
Cassia alata extract is a natural medicinal preparation derived from the Cassia alata plant (also known as Senna alata), which grows in tropical regions. It contains numerous bioactive compounds including flavonoids (quercetin, kaempferol, chrysoeriol), anthraquinones, alkaloids, tannins, phenolics, terpenes, and saponins. The extract exhibits multiple pharmacological properties including antifungal, antibacterial, anti-inflammatory, antioxidant, anticonvulsant, sedative, antiviral, antidiabetic, and antihyperlipidemic effects. It is primarily used for treating various skin conditions such as ringworm, fungal infections, eczema, and psoriasis.
- Other names
- Ketepeng CinaGelenggang
02
Targets
CYP51A1 (Sterol 14α-demethylase)15-LOX (Lysyl Oxidase)AMY (Pancreatic alpha-amylase)Sucrase-Isomaltase
Beyond the preview
Go deeper on cassia alata extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cassia alata extract.